FYN and drug-induced dyskinesia: If a comparable phenomenon also occurs in the striatum, one might expect that blocking the A2A activity could prevent the Fyn-mediated tyrosine NR2B phosphorylation process involved in the development of L-Dopa sensitization [36] and of dyskinesia [37,38] when the direct D1 striatal pathway is stimulated.